Title: 4 ‘T’ for success – Theory, Tool, Think, and Talk

Thursday, Aug 14th, 2025

Speaker: J. Jack Lee, Professor

University of Texas MD Anderson Cancer Center

J. Jack Lee, Ph.D., M.S., D.D.S. is Professor of Biostatistics and Kenedy Foundation Chair in Cancer Research at the University of Texas MD Anderson Cancer Center. His areas of expertise include design and analysis of cancer clinical trials, Bayesian adaptive designs, statistical computation/graphics, drug combination studies, biomarkers identification and validation, and statistical methods for precision medicine. In over 30 years at MD Anderson, Dr. Lee has been working with many multidisciplinary research teams and providing biostatistical support to clinical, translational, and basic science studies. He is an elected Fellow of American Statistical Association, Society for Clinical Trials, and American Association for the Advancement of Science. He has published extensively in statistical and medical journals. He co-authored two books entitled: “Bayesian Adaptive Methods for Clinical Trials” and “Model-Assisted Bayesian Designs for Dose Finding and Optimization: Methods and Applications.” Dr. Lee received his D.D.S. from National Taiwan University in 1982 and M.S. and Ph.D. in Biostatistics from University of California, Los Angeles in 1984 and 1989, respectively.

Abstract

TBD

Thursday, Aug 14th, 2025

Speaker: Lixin Gao

President of Biopier

Lixin Gao is the Founder and President of BioPier Inc. Following its acquisition by Veramed in 2024, he continues to lead BioPier, LLC as President, overseeing U.S. operations within Veramed’s global biometrics organization. Known in the biopharma industry for his hands-on leadership and focus on quality, timeliness, and operational efficiency, Lixin began his career in 1996 as a statistical programmer at Parexel. He founded BioPier in 2006 and has since built it into a trusted partner for top pharmaceutical companies, widely recognized for its expertise in fast-track study analysis and regulatory submission support. Under his leadership, BioPier has played a pivotal role in the approval of 15 innovative drugs, positively impacting countless lives through transformative treatments. Lixin earned an MS in Applied Statistics from WPI, complemented by a background in Theoretical Physics and programming. A dedicated endurance athlete, he has completed over 20 marathons and multiple 70.3 Ironman races.

Abstract

TBD